73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
{{items.name}}
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
Oncology
α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC
November 28,2024
Latest Articles
Investigating mechanisms of aggressive glioblastoma tumor growth

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr
Updated on: March 30,2024
Investigating mechanisms of aggressive glioblastoma tumor growth

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr
Updated on:March 30,2024
Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b
Updated on: March 30,2024
Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b
Updated on:March 30,2024
Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca
Updated on: August 28,2024
Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca
Updated on:August 28,2024
New insight into aggressive breast cancers

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv
Updated on: March 06,2024
New insight into aggressive breast cancers

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv
Updated on:March 06,2024
Researchers peer inside cells to spy on cancer's on-off switch

Researchers peer inside cells to spy on cancer's on-off switch

by Lisa Marshall,University of Colorado at BoulderCredit: University of Colorado at BoulderForty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins ca
Updated on: June 06,2024
Researchers peer inside cells to spy on cancer's on-off switch

Researchers peer inside cells to spy on cancer's on-off switch

by Lisa Marshall,University of Colorado at BoulderCredit: University of Colorado at BoulderForty years after researchers first discovered it in fruit flies, a once-obscure cluster of proteins ca
Updated on:June 06,2024
Fighting aggressive blood cancer ages and exhausts immune cells, study shows

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm
Updated on: January 22,2024
Fighting aggressive blood cancer ages and exhausts immune cells, study shows

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm
Updated on:January 22,2024
Driving rhabdomyosarcoma into differentiation through targeted transformation of tumor cells

Driving rhabdomyosarcoma into differentiation through targeted transformation of tumor cells

by Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)Induction of myogenic differentiation and reduction of cell division in rhabdomyosarcoma cells after reducing of the amount
Updated on: January 07,2024
Driving rhabdomyosarcoma into differentiation through targeted transformation of tumor cells

Driving rhabdomyosarcoma into differentiation through targeted transformation of tumor cells

by Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)Induction of myogenic differentiation and reduction of cell division in rhabdomyosarcoma cells after reducing of the amount
Updated on:January 07,2024
AAFP still recommends CRC screening from age 50 to 75

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc
Updated on: March 27,2024
AAFP still recommends CRC screening from age 50 to 75

AAFP still recommends CRC screening from age 50 to 75

(HealthDay)—In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer sc
Updated on:March 27,2024
Opportunistic colonizers: Selectively targeting tumor cells with bacteria

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac
Updated on: July 08,2024
Opportunistic colonizers: Selectively targeting tumor cells with bacteria

Opportunistic colonizers: Selectively targeting tumor cells with bacteria

by TranSpreadC@ECN-PL delivers CXB to tumor cells via liposomes anchored to the cell surface and promotes immune cell recruitment to the tumor. The self-lysis circuit ensures that C@ECN-PL does not ac
Updated on:July 08,2024
Incidence of Hodgkin lymphoma up in least deprived areas

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me
Updated on: March 21,2024
Incidence of Hodgkin lymphoma up in least deprived areas

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me
Updated on:March 21,2024
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Updated on: October 21,2024
Clinical trial finds new drug significantly extends lives of breast cancer patients

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa
Updated on:October 21,2024
Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find
Updated on: January 22,2024
Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find
Updated on:January 22,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com